Archive: Clinical Trials

How Medical Contact Centers Power Patient Recruitment for Clinical Trials

Author:
Posted: July 9th, 2024

Patient recruitment is one of the most critical and challenging aspects of clinical trials. Medical contact centers can be beneficial to the entire healthcare industry, but we’re going to focus on how they can help clinical trial participation. These contact centers drive study enrollment by improving the patient recruitment process through patient engagement and education.

Compensation norms create inequity in clinical trials.

Author: SubjectWell
Posted: December 7th, 2022

Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes

Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation.

Author: SubjectWell
Posted: November 8th, 2022

SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’

Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest.

Author: SubjectWell
Posted: September 8th, 2022

Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population

Spanish-speaking patients show strong interest in clinical trial participation in the US.

Author: SubjectWell
Posted: June 17th, 2022

For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers

Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic.

Author: SubjectWell
Posted: May 28th, 2022

At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was

Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression.

Author: SubjectWell
Posted: March 31st, 2022

In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes

SubjectWell expands its proven marketplace to include non-small cell lung cancer trials

Author: SubjectWell
Posted: March 14th, 2022

SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to

Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology.

Author: SubjectWell
Posted: January 4th, 2022

Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within

How to Boost Diversity in Clinical Trial Patient Recruitment

Author: tdower
Posted: March 25th, 2020

Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts.